A J Oliveira-Lima1, R Santos2, A W Hollais2, C A Gerardi-Junior3, M A Baldaia2, R Wuo-Silva2, T S Yokoyama2, J L Costa4, E L A Malpezzi-Marinho5, P C Ribeiro-Barbosa1, L F Berro6, R Frussa-Filho7, E A V Marinho8. 1. Department of Health Sciences, Universidade Estadual de Santa Cruz, Rod. Ilhéus/Itabuna, Km 16, 45662-0 Ilhéus, BA, Brazil. 2. Department of Physiology, Universidade Federal de São Paulo, R. Botucatu, 862, 04023062 São Paulo, SP, Brazil. 3. Health Division, Universidade Braz Cubas, Av. Francisco Rodrigues Filho, 1233, Mogi das Cruzes, SP, Brazil. 4. Forensic Toxicology and Chemistry Laboratory, Criminalistics Institute of São Paulo, São Paulo, SP, Brazil. 5. Department of Biological Sciences, Universidade Estadual de Santa Cruz, Rod. Ilhéus/Itabuna, Km 16, 45662-0 Ilhéus, BA, Brazil. 6. Department of Psychobiology, Universidade Federal de São Paulo, R. Botucatu, 862, 04023062 São Paulo, SP, Brazil. Electronic address: berro.lf@gmail.com. 7. Department of Psychobiology, Universidade Federal de São Paulo, R. Botucatu, 862, 04023062 São Paulo, SP, Brazil. 8. Department of Health Sciences, Universidade Estadual de Santa Cruz, Rod. Ilhéus/Itabuna, Km 16, 45662-0 Ilhéus, BA, Brazil. Electronic address: edumarinho@hotmail.com.
Abstract
BACKGROUND: Hallucinogenic drugs were used to treat alcoholic patients in the past, and recent developments in the study of hallucinogens led to a renewal of interest regarding the application of these drugs in the treatment of addiction. In this scenario, accumulating evidence suggests that the hallucinogenic brew ayahuasca (Aya) may have therapeutic effects on substance abuse problems. METHODS: We investigated the effects of Aya on spontaneous locomotor activity and ethanol(Eth)-induced hyperlocomotion and subsequent locomotor sensitization by a two-injection protocol. Additionally, we tested the effect of Aya on an 8-day counter-sensitization protocol to modify sensitized responses induced by a repeated treatment with Eth (1.8g/kg) for 8 alternate days. RESULTS: Aya showed high sensitivity in preventing the development of Eth-induced behavioral sensitization, attenuating it at all doses (30, 100, 200, 300 or 500 mg/kg) without modifying spontaneous locomotor activity. At the highest doses (300 and 500 mg/kg), Aya also showed selectivity to both acute and sensitized Eth responses. Finally, a counter-sensitization strategy with 100 or 300 mg/kg of Aya for 8 consecutive days after the establishment of Eth-induced behavioral sensitization was effective in blocking its subsequent expression on an Eth challenge. CONCLUSIONS: We demonstrated that Aya not only inhibits early behaviors associated with the initiation and development of Eth addiction, but also showed effectiveness in reversing long-term drug effects expression, inhibiting the reinstatement of Eth-induced behavioral sensitization when administered in the Eth-associated environment.
BACKGROUND: Hallucinogenic drugs were used to treat alcoholicpatients in the past, and recent developments in the study of hallucinogens led to a renewal of interest regarding the application of these drugs in the treatment of addiction. In this scenario, accumulating evidence suggests that the hallucinogenic brew ayahuasca (Aya) may have therapeutic effects on substance abuse problems. METHODS: We investigated the effects of Aya on spontaneous locomotor activity and ethanol(Eth)-induced hyperlocomotion and subsequent locomotor sensitization by a two-injection protocol. Additionally, we tested the effect of Aya on an 8-day counter-sensitization protocol to modify sensitized responses induced by a repeated treatment with Eth (1.8g/kg) for 8 alternate days. RESULTS: Aya showed high sensitivity in preventing the development of Eth-induced behavioral sensitization, attenuating it at all doses (30, 100, 200, 300 or 500 mg/kg) without modifying spontaneous locomotor activity. At the highest doses (300 and 500 mg/kg), Aya also showed selectivity to both acute and sensitized Eth responses. Finally, a counter-sensitization strategy with 100 or 300 mg/kg of Aya for 8 consecutive days after the establishment of Eth-induced behavioral sensitization was effective in blocking its subsequent expression on an Eth challenge. CONCLUSIONS: We demonstrated that Aya not only inhibits early behaviors associated with the initiation and development of Eth addiction, but also showed effectiveness in reversing long-term drug effects expression, inhibiting the reinstatement of Eth-induced behavioral sensitization when administered in the Eth-associated environment.
Authors: Rafael G Dos Santos; Flávia L Osório; José Alexandre S Crippa; Jordi Riba; Antônio W Zuardi; Jaime E C Hallak Journal: Ther Adv Psychopharmacol Date: 2016-03-18
Authors: Aboagyewaah Oppong-Damoah; Kristen E Curry; Bruce E Blough; Kenner C Rice; Kevin S Murnane Journal: Psychopharmacology (Berl) Date: 2019-07-15 Impact factor: 4.530
Authors: Lucas Silva Rodrigues; Giordano Novak Rossi; Juliana Mendes Rocha; Flávia L Osório; José Carlos Bouso; Jaime E Cecílio Hallak; Rafael G Dos Santos Journal: Eur Arch Psychiatry Clin Neurosci Date: 2021-04-29 Impact factor: 5.270
Authors: Brian Rush; Olivia Marcus; Sara García; Anja Loizaga-Velder; Gabriel Loewinger; Ariane Spitalier; Fernando Mendive Journal: Front Pharmacol Date: 2021-05-19 Impact factor: 5.810
Authors: Paulo Cesar Ribeiro Barbosa; Luís F Tófoli; Michael P Bogenschutz; Robert Hoy; Lais F Berro; Eduardo A V Marinho; Kelsy N Areco; Michael J Winkelman Journal: Front Psychiatry Date: 2018-04-24 Impact factor: 4.157